JP2016529316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529316A5 JP2016529316A5 JP2016540407A JP2016540407A JP2016529316A5 JP 2016529316 A5 JP2016529316 A5 JP 2016529316A5 JP 2016540407 A JP2016540407 A JP 2016540407A JP 2016540407 A JP2016540407 A JP 2016540407A JP 2016529316 A5 JP2016529316 A5 JP 2016529316A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- vector
- influenza
- animal
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 22
- 241001465754 Metazoa Species 0.000 claims 7
- 206010022000 influenza Diseases 0.000 claims 6
- 244000052769 pathogen Species 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000000241 respiratory effect Effects 0.000 claims 5
- 241000725643 Respiratory syncytial virus Species 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 201000004792 malaria Diseases 0.000 claims 4
- 230000001717 pathogenic effect Effects 0.000 claims 4
- 241000193738 Bacillus anthracis Species 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 3
- 108700019146 Transgenes Proteins 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- 241000712461 unidentified influenza virus Species 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 2
- 206010069767 H1N1 influenza Diseases 0.000 claims 2
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims 2
- 241000430519 Human rhinovirus sp. Species 0.000 claims 2
- 102100024324 Toll-like receptor 3 Human genes 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 206010064097 avian influenza Diseases 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 201000010740 swine influenza Diseases 0.000 claims 2
- 241000272525 Anas platyrhynchos Species 0.000 claims 1
- XFTWUNOVBCHBJR-UHFFFAOYSA-N Aspergillomarasmine A Chemical group OC(=O)C(N)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O XFTWUNOVBCHBJR-UHFFFAOYSA-N 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 241000711573 Coronaviridae Species 0.000 claims 1
- 241000709661 Enterovirus Species 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 claims 1
- 102000003886 Glycoproteins Human genes 0.000 claims 1
- 108090000288 Glycoproteins Proteins 0.000 claims 1
- 101710154606 Hemagglutinin Proteins 0.000 claims 1
- 241000598171 Human adenovirus sp. Species 0.000 claims 1
- 208000002979 Influenza in Birds Diseases 0.000 claims 1
- 241000186359 Mycobacterium Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 102000005348 Neuraminidase Human genes 0.000 claims 1
- 108010006232 Neuraminidase Proteins 0.000 claims 1
- 102000011931 Nucleoproteins Human genes 0.000 claims 1
- 108010061100 Nucleoproteins Proteins 0.000 claims 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 claims 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 1
- 108010039918 Polylysine Proteins 0.000 claims 1
- 101710194807 Protective antigen Proteins 0.000 claims 1
- 101710176177 Protein A56 Proteins 0.000 claims 1
- 206010037742 Rabies Diseases 0.000 claims 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 108010055044 Tetanus Toxin Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 239000008241 heterogeneous mixture Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 231100000518 lethal Toxicity 0.000 claims 1
- 230000001665 lethal effect Effects 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 229920000656 polylysine Polymers 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- 230000001932 seasonal effect Effects 0.000 claims 1
- 229940118376 tetanus toxin Drugs 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361874505P | 2013-09-06 | 2013-09-06 | |
| US61/874,505 | 2013-09-06 | ||
| PCT/US2014/054234 WO2015035128A1 (en) | 2013-09-06 | 2014-09-05 | Methods and compositions for viral vectored vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016529316A JP2016529316A (ja) | 2016-09-23 |
| JP2016529316A5 true JP2016529316A5 (enExample) | 2017-10-19 |
Family
ID=52625855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540407A Pending JP2016529316A (ja) | 2013-09-06 | 2014-09-05 | ウイルスベクター化ワクチンのための方法及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150071964A1 (enExample) |
| EP (1) | EP3041503A4 (enExample) |
| JP (1) | JP2016529316A (enExample) |
| KR (1) | KR20160049010A (enExample) |
| AU (1) | AU2014315124A1 (enExample) |
| CA (1) | CA2923406A1 (enExample) |
| MX (1) | MX2016002823A (enExample) |
| WO (1) | WO2015035128A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10183069B2 (en) | 2011-03-21 | 2019-01-22 | Altimmune Inc. | Rapid and prolonged immunologic-therapeutic |
| WO2018071233A1 (en) | 2016-10-12 | 2018-04-19 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| KR20220036909A (ko) * | 2019-04-06 | 2022-03-23 | 알티뮨 인크. | 광범위하고 오래 지속되는 인플루엔자 백신 |
| WO2021216569A1 (en) * | 2020-04-20 | 2021-10-28 | Greffex, Inc. | Engineering broadly reactive coronavirus vaccines and related designs and uses |
| US20240216364A1 (en) | 2021-04-28 | 2024-07-04 | Enyo Pharma | Strong potentiation of tlr3 agonists effects using fxr agonists as a combined treatment |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2712673C2 (de) * | 1977-03-23 | 1983-12-15 | Krauss U. Reichert Gmbh + Co Kg Spezialmaschinenfabrik, 7012 Fellbach | Stoßmessermaschine |
| US20030134815A1 (en) * | 1991-08-20 | 2003-07-17 | The Govt. Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Adenovirus mediated transfer of genes to the gastrointestinal tract |
| WO2005102278A1 (en) * | 2002-07-03 | 2005-11-03 | Oncovir, Inc. | Method for preparation of poly-iclc and uses thereof |
| US8592391B2 (en) * | 2003-07-01 | 2013-11-26 | Andres Salazar | Method for therapeutic, clinical and veterinary use poly-ICLC |
| WO2005013898A2 (en) * | 2003-07-11 | 2005-02-17 | Vaxin, Inc. | Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| US7834064B2 (en) * | 2005-01-03 | 2010-11-16 | Andres Mario Salazar | Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs |
| JP2008541730A (ja) * | 2005-05-23 | 2008-11-27 | ヴァクシン インコーポレイテッド | 高力価かつ複製コンピテントアデノウイルス不含である組換えアデノウイルスベクターの迅速な作成法 |
| KR101345936B1 (ko) * | 2005-08-15 | 2013-12-31 | 박신 인크. | 비복제성 벡터화된 백신 투여에 의한 조류 면역화 |
| HUE030281T2 (en) * | 2006-02-28 | 2017-05-29 | Vaxart Inc | Chimeric adenoviral vectors and double-stranded RNA as a TLR3 agonist |
| AU2009253780B2 (en) * | 2008-06-05 | 2014-08-14 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| WO2010037027A2 (en) * | 2008-09-26 | 2010-04-01 | Auburn University | Immunization of avians by mucosal administration of non-replicating vectored vaccines |
| US9603919B2 (en) * | 2009-03-31 | 2017-03-28 | Japan As Represented By The Director-General Of National Institute Of Infectious Diseases | Method for prophylaxis of influenza using vaccine for intranasal administration |
| EP2440251A4 (en) * | 2009-06-09 | 2013-01-16 | Defyrus Inc | INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION |
| CA2829916C (en) * | 2011-03-21 | 2019-08-20 | Vaxin Inc. | Intranasal administration of an adenovirus vector to induce a protective immune response to an inhalation pathogen |
-
2014
- 2014-09-05 AU AU2014315124A patent/AU2014315124A1/en not_active Abandoned
- 2014-09-05 CA CA2923406A patent/CA2923406A1/en not_active Abandoned
- 2014-09-05 US US14/478,040 patent/US20150071964A1/en not_active Abandoned
- 2014-09-05 MX MX2016002823A patent/MX2016002823A/es unknown
- 2014-09-05 WO PCT/US2014/054234 patent/WO2015035128A1/en not_active Ceased
- 2014-09-05 KR KR1020167008956A patent/KR20160049010A/ko not_active Withdrawn
- 2014-09-05 EP EP14841665.4A patent/EP3041503A4/en not_active Withdrawn
- 2014-09-05 JP JP2016540407A patent/JP2016529316A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rajao et al. | Swine as a model for influenza A virus infection and immunity | |
| JP2016529316A5 (enExample) | ||
| JP2013126989A5 (enExample) | ||
| AR090469A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| IL253187B (en) | Novel multivalent nanoparticle-based vaccines | |
| PH12018500856A1 (en) | Respiratory syncytial virus vaccine | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| WO2009068992A8 (en) | Vaccination with multiple clades of h5 influenza a virus | |
| ES2588183T3 (es) | Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal | |
| EP4233898A3 (en) | Influenza mrna vaccines | |
| EP4349405A3 (en) | Respiratory virus vaccines | |
| WO2017070620A3 (en) | Broad spectrum influenza virus vaccine | |
| PH12015501482A1 (en) | Nasal influenza vaccine composition | |
| WO2010037027A3 (en) | Immunization of avians by mucosal administration of non-replicating vectored vaccines | |
| WO2009092038A8 (en) | Influenza dna vaccination and methods of use thereof | |
| WO2015052543A3 (en) | Malaria vaccination | |
| AU2011280259A8 (en) | Influenza vaccine | |
| Lambe | Novel viral vectored vaccines for the prevention of influenza | |
| EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
| WO2011156641A3 (en) | Microneedle arrays for active agent delivery | |
| PE20170429A1 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
| EP2329845A4 (en) | BIRD GRAPEVIRUS ANTIGEN AND BOOSTER IMMUNIZATION PROCEDURE FOR BIRD FLUID VACCINE IN COMBINATION WITH A MUCOSAL ADJUVAN WITH EFFICACY THROUGH ORAL ADMINISTRATION | |
| CL2012003219A1 (es) | Parapoxvirus recombinante que comprende un parapoxvirus y adn heterólogo derivado de un virus de la rabia; procedimiento de preparación de dicho parapoxvirus; composicion inmunogénica; uso de la composicion para inducir respuesta inmunitaria contra el virus de la rabia en un animal. | |
| WO2012061239A3 (en) | Novel vaccines against pandemic influenza virus a/h1n1 | |
| WO2008115785A3 (en) | Multivalent avian influenza vaccines and methods |